Intratumoral Immunotherapy: From Trial Design to Clinical Practice.
Champiat S, Tselikas L, Farhane S, Raoult T, Texier M, Lanoy E, Massard C, Robert C, Ammari S, De Baère T, Marabelle A.
Champiat S, et al.
Clin Cancer Res. 2021 Feb 1;27(3):665-679. doi: 10.1158/1078-0432.CCR-20-0473. Epub 2020 Sep 17.
Clin Cancer Res. 2021.
PMID: 32943460
Review.
Preclinical studies have demonstrated that intratumoral injections of immunostimulatory products (oncolytics, pattern recognition receptor agonists,) that are able to trigger type I IFN release and enhance tumor antigen presentation on immune cells could generate a strong …
Preclinical studies have demonstrated that intratumoral injections of immunostimulatory products (oncolytics, pattern recognition receptor a …